UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The lancet oncology, ISSN 1470-2045, 10/2019, Volume 20, Issue 10, pp. 1349 - 1359
Journal Article
The Journal of urology, ISSN 0022-5347, 08/2018, Volume 200, Issue 2, pp. 351 - 352
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 2, pp. 138 - 148
no | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Multiple tumors. Solid tumors. Tumors in childhood (general aspects) | Medical sciences | Tumors | Prednisone - adverse effects | Double-Blind Method | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Abiraterone Acetate | Prostatic Neoplasms - mortality | Antineoplastic Agents, Hormonal - adverse effects | Disease-Free Survival | Neoplasm Metastasis | Prostatic Neoplasms - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Survival Analysis | Androstadienes - therapeutic use | Androstadienes - adverse effects | Prednisone - therapeutic use | Prostatic Neoplasms - drug therapy | Drugs | Dose-response relationship (Biochemistry) | Chemotherapy | Usage | Care and treatment | Patient outcomes | Product/Service Evaluations | Drug therapy | Prostate cancer | Cancer | Clinical trials | Cancer therapies | Regulatory approval | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2009, Volume 301, Issue 1, pp. 39 - 51
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Double-Blind Method | Humans | Middle Aged | Male | Neoplasms - prevention & control | Treatment Outcome | Prostatic Neoplasms - epidemiology | Selenomethionine - therapeutic use | Selenium - therapeutic use | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Vitamin E - therapeutic use | Aged | Prostatic Neoplasms - prevention & control | Dietary Supplements | Neoplasms - epidemiology | Disease prevention | Clinical trials | Selenium | Vitamin E | Prostate cancer | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 08/2020, Volume 38, Issue 24, pp. 2709 - 2711
Journal Article
BMC cancer, ISSN 1471-2407, 02/2020, Volume 20, Issue 1, pp. 125 - 125
Human papillomavirus | Transoral surgery | Quality of Life | De-escalation | Head and neck cancer | Oropharynx | Radiotherapy | Randomized controlled trial | Survival | Life Sciences & Biomedicine | Oncology | Science & Technology | Complications and side effects | Squamous cell carcinoma | Care and treatment | Patient outcomes | Throat cancer | Papillomavirus infections | Methods | Oral surgery | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 697 - 710
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Immunohistochemistry | South America | Head and Neck Neoplasms - virology | Prospective Studies | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Neoplasm Recurrence, Local - virology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | North America | Cisplatin - administration & dosage | Neoplasm Recurrence, Local - pathology | Head and Neck Neoplasms - chemistry | Neoplasm Metastasis | Carcinoma, Squamous Cell - mortality | Cyclin-Dependent Kinase Inhibitor p16 - analysis | Fluorouracil - administration & dosage | Time Factors | Female | Retrospective Studies | Biomarkers, Tumor - analysis | Europe | Head and Neck Neoplasms - drug therapy | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Squamous Cell - chemistry | Treatment Outcome | Papillomaviridae - isolation & purification | Neoplasm Recurrence, Local - chemistry | Head and Neck Neoplasms - pathology | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Biopsy | Carcinoma, Squamous Cell - secondary | Aged | Head and Neck Neoplasms - mortality | Care and treatment | Relapse | Carcinoma | Monoclonal antibodies | Product development | Metastasis | Cisplatin | Cancer | Diseases | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 08/2007, Volume 25, Issue 24, pp. 3766 - 3773
Biological and medical sciences | Medical sciences | Otorhinolaryngology. Stomatology | Otorhinolaryngology (head neck, general aspects and miscellaneous) | Tumors | Niacinamide - analogs & derivatives | Nasopharyngeal Neoplasms - mortality | raf Kinases - antagonists & inhibitors | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Benzenesulfonates - therapeutic use | Phenylurea Compounds | Nasopharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Adult | Female | Nasopharyngeal Neoplasms - drug therapy | Pyridines - therapeutic use | Head and Neck Neoplasms - drug therapy | Neoplasm Recurrence, Local | Survival Rate | Disease Progression | Head and Neck Neoplasms - pathology | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Squamous Cell - secondary | Aged | Head and Neck Neoplasms - mortality | Index Medicus
Journal Article
Expert opinion on emerging drugs, ISSN 1472-8214, 10/2018, Volume 23, Issue 4, pp. 271 - 282
Journal Article
The Journal of urology, 08/2018, Volume 200, Issue 2, p. 351
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 769 - 776
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Albumins - chemistry | Albumin-Bound Paclitaxel | Humans | Middle Aged | Ureteral Neoplasms - pathology | Male | Drug Carriers - chemistry | Urothelium - pathology | Nanoparticles | Ureteral Neoplasms - drug therapy | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Albumins - adverse effects | Time Factors | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Paclitaxel - administration & dosage | Antineoplastic Agents, Phytogenic - adverse effects | Carcinoma - secondary | Carcinoma - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Paclitaxel - adverse effects | Albumins - administration & dosage | Antineoplastic Agents, Phytogenic - chemistry | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Chemistry, Pharmaceutical | Canada | Disease-Free Survival | Administration, Intravenous | Kidney Neoplasms - pathology | Aged | Kidney Neoplasms - drug therapy | Urothelium - drug effects | Antimitotic agents | Care and treatment | Albumin | Metastasis | Drug therapy | Antineoplastic agents | Cancer | Index Medicus
Journal Article